Functional CD8+ T cells were upregulated in tumors from mice treated with TAK-243 or the combination (Fig. 4G), and importantly, CD8+ T cells were necessary for full tumor control mediated by TAK-243 or the combination (Fig. 4H). This evidence concerns the gene CD8A and neoplasm.